Sierrasesúmaga L, Antillón F, Cañadell J, Calvo F, Barona P, Villa I
Departamento de Pediatría, Facultad de Medicina, Universidad de Navarra, Pamplona.
Med Clin (Barc). 1992 Jun 20;99(4):121-4.
In order to cure Ewing's sarcoma it is necessary to have an approach which considers the radical local control on the sites of macroscopic disease, along with the systemic control of micrometastases. On the present study the experience of the authors in analyzed, remarking the role of cytoreduction surgery on curability.
From January 1982 to August 1991, 24 patients with the mean age 13 years, 14 boys and 10 girls, previously untreated and with a pathology proven diagnosis have been treated by the authors. The treatment protocol included: alternating chemotherapy with cyclophosphamide, adriamycin, methotrexate, bleomycin, actinomycin D and vincristine; administered simultaneously with preoperative external radiation with a volume that completely included the affected bone and surrounding soft tissues for a total dose of 45 Gy/4.5 weeks. After a resting period of 4 weeks, resection of the involved bone and adjacent healthy bone was performed, followed by a single dose of 10-15 Gy of intraoperative radiotherapy to the tumor bed. Subsequently a custom prostheses or allograft was implanted.
Twenty patients had localized disease and 4 had metastatic disease at diagnosis. In 16 cases the tumor was in extremities, 5 axial, and 3 extraskeletical. In 15 patients surgery with limb sparing techniques was performed, 8 had en block resection and one amputation (calcaneous location). At the time of this report 21 patient are alive (87%). Four had disease progression, of this 3 had died (12%). The actuarial disease free survival rate is 80% +/- 9% with a follow-up of 104 months, being the mean survival time of 85.5 months.
The cytoreduction surgery included into a multidisciplinary approach permits to achieve a high rate of cure in Ewing's sarcoma. The toxicity of the program can be considered acceptable.
为治愈尤因肉瘤,有必要采用一种既考虑对宏观病灶部位进行根治性局部控制,又考虑对微转移进行全身控制的方法。在本研究中,作者分析了自身经验,强调了减瘤手术在治愈方面的作用。
1982年1月至1991年8月,作者治疗了24例平均年龄13岁的患者,其中14例为男孩,10例为女孩,这些患者均未经治疗且病理诊断明确。治疗方案包括:交替使用环磷酰胺、阿霉素、甲氨蝶呤、博来霉素、放线菌素D和长春新碱进行化疗;同时在术前进行外照射,照射范围完全覆盖患骨及周围软组织,总剂量为45 Gy/4.5周。休息4周后,切除受累骨骼及相邻健康骨骼,随后对肿瘤床进行单次10 - 15 Gy的术中放疗。随后植入定制假体或同种异体移植物。
20例患者诊断时为局限性疾病,4例为转移性疾病。16例肿瘤位于四肢,5例位于轴骨,3例位于骨骼外。15例患者采用保肢技术进行手术,8例进行整块切除,1例截肢(跟骨部位)。在本报告发布时,21例患者存活(87%)。4例疾病进展,其中3例死亡(12%)。无病生存率的精算率为80%±9%,随访104个月,平均生存时间为85.5个月。
纳入多学科方法的减瘤手术能够在尤因肉瘤中实现较高的治愈率。该方案的毒性可认为是可接受的。